Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro

Journal of Applied Toxicology

Volumn 34, Issue 12, 2014, Pages 1311-1319

  Bunel, Valérian ^a   Antoine, Marie Hélène ^a   Nortier, Joëlle ^a   Duez, Pierre ^a   Stévigny, Caroline ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Apoptosis; Cisplatin; HK 2 cells; Regeneration; Schizandrin; Schizandrin B; catenin

Indexed keywords

BETA CATENIN; CISPLATIN; SCHIZANDRIN; SCHIZANDRIN B; ANTINEOPLASTIC AGENT; COLLAGEN; CYCLOOCTANE DERIVATIVE; LIGNAN; POLYCYCLIC HYDROCARBON; PROTECTIVE AGENT;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY TUBULE CELL; NEPHROTOXICITY; RENAL PROTECTION; BIOSYNTHESIS; CELL CYCLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECTS; EPITHELIUM CELL; FRUIT; ISOLATION AND PURIFICATION; KIDNEY PROXIMAL TUBULE; PATHOLOGY; SCHISANDRA;

ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL LINE; CELL SURVIVAL; CISPLATIN; COLLAGEN; CYCLOOCTANES; EPITHELIAL CELLS; FRUIT; HUMANS; KIDNEY TUBULES, PROXIMAL; LIGNANS; MOLECULAR STRUCTURE; POLYCYCLIC COMPOUNDS; PROTECTIVE AGENTS; SCHISANDRA;

EID: 84911811948     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2951     Document Type: Article

References (43)

1. Barabas K, Milner R, Lurie D, Adin C. 2008. Cisplatin: a review of toxicities and therapeutic applications. Vet. Comp. Oncol. 6: 1-18.
2. Bensky D, Gamble A, Kaptchuk T, Bensky L. 1986. Chinese Herbal Medicine: Materia Medica. Eastland Press: Seattle.
3. Bozic M, de Rooij J, Parisi E, Ortega MR, Fernandez E, Valdivielso JM. 2011. Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells. J. Am. Soc. Nephrol. 22(6):1099-1111.
4. Council of Europe. 2007. European Pharmacopoeia 6.0 Strasbourg, Council of Europe.
5. Docherty NG, O'Sullivan OE, Healy DA, Murphy M, O'Neill AJ, Fitzpatrick JM, Watson RW. 2006. TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am. J. Physiol. Renal Physiol. 290(5):F1202-F1212.
6. EMEA (European Medicines Agency) 2008. Reflection Paper on the Adaptogenic Concept. EMEA. HMPC: London. EMEA/HMPC/102655/2007.
7. Geback T, Schulz MM, Koumoutsakos P, Detmar M. 2009. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46(4):265-274.
8. Hao S, He W, Li Y, Ding H, Hou Y, Nie J, Hou FF, Kahn M, Liu Y. 2011. Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis. J. Am. Soc. Nephrol. 22 (9):1642-1653.
9. Havasi A, Borkan SC. 2011. Apoptosis and acute kidney injury. Kidney Int. 80:29-40.
10. He W, Kang YS, Dai C, Liu Y. 2011. Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J. Am. Soc. Nephrol. 22:90-103.
11. Hilal G, Albert C, Vallée M. 2005. Mécanismes impliqués dans la néphrotoxicité. Ann. Biol. Clin. Qué. 42(3):29-35.
12. Jamieson ER, Lippard SJ. 1999. Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99(9):2467-2498.
13. Jeong SI, Kim SJ, Kwon TH, Yu KY, Kim SY. 2012. Schizandrin prevents damage of murine mesangial cells via blocking NADPH oxidase-induced ROS signaling in high glucose. Food Chem. Toxicol. 50(3-4):1045-1053.
14. Lee SB, Kalluri R. 2010. Mechanistic connection between inflammation and fibrosis. Kidney Int. 78 (Suppl. 119): S22-S26.
15. Lee TH, Jung CH, Lee DH. 2012. Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats. Food Chem. Toxicol. 50(12):4239-4245.
16. Liu Y. 2010. New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21(2):212-222.
17. Megyesi J, Andrade L, Vieira JM, Jr, Safirstein RL, Price PM. 2002. Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am. J. Physiol. Renal Physiol. 283(4):F810-816.
18. Nagwani S, Tripathi YB. 2010. Amelioration of cisplatin induced nephrotoxicity by PTY: a herbal preparation. Food Chem. Toxicol. 48(8-9): 2253-2258.
19. Nitha B, Janardhanan KK. 2008. Aqueous-ethanolic extract of morel mushroom mycelium Morchella esculenta, protects cisplatin and gentamicin induced nephrotoxicity in mice. Food Chem. Toxicol. 46(9):3193-3199.
20. Pabla N, Dong Z. 2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73(9):994-1007.
21. Panossian A, Wikman G. 2008. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J. Ethnopharmacol. 118(2):183-212.
22. Park EJ, Chun JN, Kim SH, Kim CY, Lee HJ, Kim HK, Park JK, Lee SW, So I, Jeon JH. 2012. Schisandrin B suppresses TGFbeta1 signaling by inhibiting Smad2/3 and MAPK pathways. Biochem. Pharmacol. 83(3):378-384.
23. Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, Verbeelen D, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. 2008. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 73(5):595-607.
24. Price PM, Safirstein RL, Megyesi J. 2009. The cell cycle and acute kidney injury. Kidney Int. 76(6):604-613.
25. Reagan-Shaw S, Nihal M, Ahmad N. 2008. Dose translation from animal to human studies revisited. FASEB J. 22(3):659-661.
26. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. 1994. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45:48-57.
27. dos Santos NA, Carvalho Rodrigues MA, Martins NM, dos Santos AC. 2012. Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch. Toxicol. 86(8):1233-1250.
28. Sohn SH, Lee EY, Lee JH, Kim Y, Shin M, Hong M, Bae H. 2009a. Screening of herbal medicines for recovery of acetaminophen-induced nephrotoxicity. Environ. Toxicol. Pharmacol. 27(2):225-230.
29. Sohn SH, Lee H, Nam JY, Kim SH, Jung HJ, Kim Y, Shin M, Hong M, Bae H. 2009b. Screening of herbal medicines for the recovery of cisplatin-induced nephrotoxicity. Environ. Toxicol. Pharmacol. 28(2):206-212.
30. Stacchiotti A, Li Volti G, Lavazza A, Schena I, Aleo MF, Rodella LF, Rezzani R. 2011. Different role of Schisandrin B on mercury-induced renal damage in vivo and in vitro. Toxicology 286(1-3):48-57.
31. Urruticoechea A, Smith IE, Dowsett M. 2005. Proliferation marker Ki-67 in early breast cancer. J. Clin. Oncol. 23(28):7212-7220.
32. Valcu M, Valcu CM. 2011. Data transformation practices in biomedical sciences. Nat. Methods 8(2):104-105.
33. Wojcikowski K, Johnson DW, Gobe G. 2004. Medicinal herbal extracts - renal friend or foe? Part two: herbal extracts with potential renal benefits. Nephrology 9(6):400-405.
34. Wynn TA. 2007. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117(3):524-529.
35. Wynn TA. 2010. Fibrosis under arrest. Nat. Med. 16(5):523-525.
36. Xu M, Wang G, Xie H, Huang Q, Wang W, Jia Y. 2008. Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats. J. Ethnopharmacol. 115(3):483-488.
37. Yamamoto E, Izawa T, Juniantito V, Kuwamura M, Sugiura K, Takeuchi T, Yamate J. 2010. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions. Histol. Histopathol. 25(8):995-1007.
38. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. 2010. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 16(5):535-543, 531p following 143.
39. Yao X, Panichpisal K, Kurtzman N, Nugent K. 2007. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 334(2):115-124.
40. Yoo JH, Lee HJ, Kang K, Jho EH, Kim CY, Baturen D, Tunsag J, Nho CW. 2010. Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling. Food Chem. Toxicol. 48 (8-9):2247-2252.
41. Zeisberg M, Neilson EG. 2009. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119(6):1429-1437.
42. Zeisberg M, Neilson EG. 2010. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 21(11):1819-1834.
43. Zhu S, Wang Y, Chen M, Jin J, Qiu Y, Huang M, Huang Z. 2012. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo. Am. J. Chin. Med. 40(3):551-566.